ABSTRACT
Abstract Placental magnetic resonance imaging (MRI) has been increasingly requested, especially for the evaluation of suspected cases of placental adhesive disorders, generally known as placenta accreta. Abdominal radiologists need to become familiar with normal placental anatomy, anatomical variations, the current terminology, and major placental diseases that, although rare, are important causes of maternal and fetal morbidity and mortality. The aim of this didactic pictorial essay is to illustrate various findings on placental MRI, as well as to emphasize the importance of communication between radiologists and obstetricians in the search for best practices in the management of the affected patients.
Resumo A ressonância magnética placentária tem sido cada vez mais solicitada, sobretudo na avaliação de casos suspeitos de acretismo. Os radiologistas abdominais precisam se familiarizar com a anatomia placentária normal, variações anatômicas, terminologias atuais e principais doenças placentárias que, embora raras, são causas importantes de morbimortalidade materno-fetal. O objetivo deste ensaio é ilustrar, de maneira didática, diferentes achados placentários e enfatizar a importância da comunicação entre radiologistas e obstetras na busca da melhor conduta para as pacientes.
ABSTRACT
OBJECTIVES: To evaluate transrectal ultrasound, amplitude Doppler ultrasound, conventional T2-weighted magnetic resonance imaging, spectroscopy and dynamic contrast-enhanced magnetic resonance imaging in localizing and locally staging low-risk prostate cancer. INTRODUCTION: Prostate cancer has been diagnosed at earlier stages and the most accepted classification for low-risk prostate cancer is based on clinical stage T1c or T2a, Gleason score <6, and prostate-specific antigen (PSA) <10 ng/ml. METHODS: From 2005 to 2006, magnetic resonance imaging was performed in 42 patients, and transrectal ultrasound in 26 of these patients. Seven patients were excluded from the study. Mean patient age was 64.94 years and mean serum PSA was 6.05 ng/ml. The examinations were analyzed for tumor identification and location in prostate sextants, detection of extracapsular extension, and seminal vesicle invasion, using surgical pathology findings as the gold standard. RESULTS: Sixteen patients (45.7 percent) had pathologically proven organ-confined disease, 11 (31.4 percent) had positive surgical margin, 8 (28.9 percent) had extracapsular extension, and 3 (8.6 percent) presented with extracapsular extension and seminal vesicle invasion. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy values for localizing low-risk prostate cancer were 53.1 percent, 48.3 percent, 63.4 percent, 37.8 percent and 51.3 percent for transrectal ultrasound; 70.4 percent, 36.2 percent, 65.1 percent, 42.0 percent and 57.7 percent for amplitude Doppler ultrasound; 71.5 percent, 58.9 percent, 76.6 percent, 52.4 percent and 67.1 percent for magnetic resonance imaging; 70.4 percent, 58.7 percent, 78.4 percent, 48.2 percent and 66.7 percent for magnetic resonance spectroscopy; 67.2 percent, 65.7 percent, 79.3 percent, 50.6 percent and 66.7 percent for dynamic contrast-enhanced magnetic resonance imaging, respectively. Sensitivity, specificity, PPV, NPV and accuracy values for detecting extracapsular extension were 33.3 percent, 92 percent, 14.3 percent, 97.2 percent and 89.7 percent for transrectal ultrasound and 50.0 percent, 77.6 percent, 13.7 percent, 95.6 percent and 75.7 percent for magnetic resonance imaging, respectively. For detecting seminal vesicle invasion, these values were 66.7 percent, 85.7 percent, 22.2 percent, 97.7 percent and 84.6 percent for transrectal ultrasound and 40.0 percent, 83.1 percent, 15.4 percent, 94.7 percent and 80.0 percent for magnetic resonance imaging. CONCLUSION: Although preliminary, our results suggest that imaging modalities have limited usefulness in localizing and locally staging clinically low-risk prostate cancer.
Subject(s)
Aged , Humans , Male , Middle Aged , Neoplasm Staging/methods , Prostatic Neoplasms/pathology , Prostatic Neoplasms , Biopsy , Contrast Media , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Predictive Value of Tests , Prostatectomy , Prostate-Specific Antigen/analysis , Risk Factors , Ultrasonography, Doppler/methodsABSTRACT
O adenocarcinoma prostático é o segundo tumor em incidência e mortalidade dentre as neoplasias malignas masculinas. Para adequada programação terapêutica é importante a distinção entre tumores confinados à próstata e aqueles com extensão extraprostática. Diferentes estudos têm demonstrado que a ressonância magnética da próstata com bobina endorretal auxilia no estadiamento local destes pacientes. Este artigo apresenta informações sobre a anatomia prostática, o aspecto tumoral à ressonância magnética, sinais de extensão tumoral extraprostática e invasão de vesículas seminais, sugestões de protocolo, princípios gerais e importância da espectroscopia de prótons, do estudo perfusional e da difusão, indicações da ressonância magnética na investigação de recidiva pós-operatória e pós-radioterapia, seu papel na detecção de lesões suspeitas em pacientes com suspeita clínico-laboratorial de adenocarcinoma prostático, além de apresentar os diagnósticos diferenciais e limitações do método.
Prostate adenocarcinoma is the second tumor in incidence and mortality among malignant neoplasms in men. The differentiation between tumors confined to the organ and those with extraprostatic extension is critical for an appropriate therapeutic planning. Different studies have demonstrated that magnetic resonance imaging of the prostate with endorectal coil is useful in the local staging of these tumors. The present article presents information on the prostate gland anatomy, the tumor aspect at magnetic resonance imaging, specific signs of extracapsular extension and seminal vesicles invasion, protocol suggestions, general principles and relevance of proton spectroscopy, perfusion and diffusion imaging, role of magnetic resonance imaging in the postoperative and post-radiotherapy detection of local tumor recurrence, and also in the detection of lesions in patients with clinical/laboratory suspicion of prostate adenocarcinoma. Additionally, the present article describes differential diagnoses and limitations of the method.